FC
ONC

Financial Consulate’s BeOne Medicines Ltd ONC Stock Holding History

Financial Consulate’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78K Buy
6
+3
+100% +$971 ﹤0.01% 998
2025
Q4 		$912 Buy
+3
New +$982 ﹤0.01% 1033

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Consulate's ONC Position: Q1 2026 in Review

Financial Consulate increased its BeOne Medicines Ltd (ONC) stake by 100% in Q1 2026, buying an estimated $971 and bringing the position to 6 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

Financial Consulate first reported a position in ONC in Q4 2025 and has held it in 2 quarters since. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Financial Consulate held 6 shares of BeOne Medicines Ltd worth $1.78K as of Q1 2026.
  • Financial Consulate bought 3 BeOne Medicines Ltd shares in Q1 2026, an estimated $971.
  • BeOne Medicines Ltd made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #998 holding.
  • Financial Consulate first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 2 quarters since.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.